Home » Topics » Regulatory

Regulatory
RSS

Remicade recommended for expanded approval in Europe

Oct. 13, 2000

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

FDA approves first and only once-monthly contraceptive for women

Oct. 10, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

First prescription drug to treat unwanted facial hair introduced in U.S.

Oct. 5, 2000

FDA approves breath-activated device with corticosteroid for asthma

Oct. 5, 2000

Novo Nordisk's liquid Norditropin now available in U.S.

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

FDA approves cream formulation of Allergan's Tazorac

Oct. 4, 2000

FDA approves Fosamax for use in men with osteoporosis

Oct. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...